This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopl [2024/10/28 11:05] – jerickson | bacteria:t3e:xopl [2025/02/13 12:36] (current) – jfpothier | ||
---|---|---|---|
Line 16: | Line 16: | ||
=== How discovered? === | === How discovered? === | ||
- | XopL was first identified in | + | XopL was first identified in //X. campestris// pv. //campestris// (//Xcc//) strain 8004 as a candidate T3E due to the presence of a plant-inducible promoter (PIP) box upstream of the CDS, //XC_4273// (Jiang |
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | < | ||
- | < | ||
- | < | ||
+ | XopL< | ||
=== Regulation === | === Regulation === | ||
Line 29: | Line 27: | ||
qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//), including //xopL//, were significantly reduced in the // | qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//), including //xopL//, were significantly reduced in the // | ||
- | The expression of //xopL// <sub>Xcc8004</ | + | The expression of // |
=== Phenotypes === | === Phenotypes === | ||
- | * | + | * XopL< |
- | < | + | * XopL//< |
- | * | + | * XopL//< |
- | < | + | * XopL//< |
- | * | + | * XopL//< |
- | < | + | * Distantly related XopL homolog XopL//< |
- | * | + | * XopL//< |
- | < | + | * XopL//< |
- | * | + | * XopL//< |
- | < | + | * XopL//< |
- | * | + | * Transient expression of XopL//< |
- | < | + | * //Xe //85-10 suppresses host autophagy by utilizing type-III effector XopL//< |
- | * | + | |
- | < | + | |
- | * | + | |
- | < | + | |
- | * | + | |
- | < | + | |
- | * | + | |
- | < | + | |
- | * | + | |
- | < | + | |
- | * | + | |
- | < | + | |
=== Localization === | === Localization === | ||
- | < | ||
- | < | ||
- | < | ||
- | < | ||
- | < | ||
- | < | ||
+ | Several localization patterns have been reported for XopL proteins in epidermal cells with some strain dependent differences. XopLs are most often tagged at the C-terminus, with the exception of the studies by Leong //et al//., 2022 and Yan //et al.//, 2019. | ||
+ | |||
+ | * __Cytosolic localization__ has been reported for XopL//< | ||
+ | * __Nuclear localization__ was reported for XopL//< | ||
+ | * __Plasma membrane localization__ has been reported for XopL< | ||
+ | * __Microtubule localization__ has been reported for XopL//< | ||
+ | * __Autophagosome localization__ has been reported for XopL//< | ||
=== Enzymatic function === | === Enzymatic function === | ||
- | XopL< | + | XopL< |
=== Interaction partners === | === Interaction partners === | ||
- | XopL CKGE_TMP_i | + | XopL< |
===== Conservation ===== | ===== Conservation ===== | ||
Line 77: | Line 63: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes (//e.g.//, //X. euvesicatoria//, | + | Yes (//e.g.//, //X. euvesicatoria//, |
=== In other plant pathogens/ | === In other plant pathogens/ | ||
Line 85: | Line 71: | ||
===== References ===== | ===== References ===== | ||
- | Adlung N (2016). Charakterisierung der Avirulenzaktivität von XopQ und Identifizierung möglicher Interaktoren von XopL aus // | + | Adlung N (2016). Charakterisierung der Avirulenzaktivität von XopQ und Identifizierung möglicher Interaktoren von XopL aus // |
- | Erickson JL, Adlung N, Lampe C, Bonas U, Schattat MH (2018). The // | + | Erickson JL, Adlung N, Lampe C, Bonas U, Schattat MH (2018). The // |
- | Huang J, Dong Y, Li N, He Y, Zhou H (2024). The type III effector XopL//< | + | Huang J, Dong Y, Li N, He Y, Zhou H (2024a). The type III effector XopL//< |
- | Huang J, Zhou H, Zhou M, Li N, Jiang B, He Y (2024). Functional analysis of type III effectors in // | + | Huang J, Zhou H, Zhou M, Li N, Jiang B, He Y (2024b). Functional analysis of type III effectors in // |
- | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification of six type III effector genes with the PIP box in // | + | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification of six type III effector genes with the PIP box in // |
Leong JX, Raffeiner M, Spinti D, Langin G, Franz-Wachtel M, Guzman AR, Kim JG, Pandey P, Minina AE, Macek B, Hafrén A, Bozkurt TO, Mudgett MB, Börnke F, Hofius D, Üstün S (2022). A bacterial effector counteracts host autophagy by promoting degradation of an autophagy component. EMBO J. 41: e110352. DOI: [[https:// | Leong JX, Raffeiner M, Spinti D, Langin G, Franz-Wachtel M, Guzman AR, Kim JG, Pandey P, Minina AE, Macek B, Hafrén A, Bozkurt TO, Mudgett MB, Börnke F, Hofius D, Üstün S (2022). A bacterial effector counteracts host autophagy by promoting degradation of an autophagy component. EMBO J. 41: e110352. DOI: [[https:// | ||
- | Liu Y, Long J, Shen D, Song C (2016). // | + | Liu Y, Long J, Shen D, Song C (2016). // |
- | Ma W, Xu X, Cai L, Cao Y, Haq F, Alfano JR, Zu B, Zou L, Chen G (2020) | + | Ma W, Xu X, Cai L, Cao Y, Haq F, Alfano JR, Zu B, Zou L, Chen G (2020). A // |
- | Ortmann S, Marx J, Lampe C, Handrick V, Ehnert TM, Zinecker S, Reimers M, Bonas U, Erickson JL (2023). A conserved microtubule-binding region in // | + | Ortmann S, Marx J, Lampe C, Handrick V, Ehnert TM, Zinecker S, Reimers M, Bonas U, Erickson JL (2023). A conserved microtubule-binding region in // |
- | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // | + | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // |
Singer AU, Schulze S, Skarina T, Xu X, Cui H, Eschen-Lippold L, Egler M, Srikumar T, Raught B, Lee J, Scheel D, Savchenko A, Bonas U (2013). A pathogen type III effector with a novel E3 ubiquitin ligase architecture. PLoS Pathog. 9: e1003121. DOI: [[https:// | Singer AU, Schulze S, Skarina T, Xu X, Cui H, Eschen-Lippold L, Egler M, Srikumar T, Raught B, Lee J, Scheel D, Savchenko A, Bonas U (2013). A pathogen type III effector with a novel E3 ubiquitin ligase architecture. PLoS Pathog. 9: e1003121. DOI: [[https:// | ||
- | Soni M, Mondal KK. (2017). // | + | Soni M, Mondal KK. (2017). // |
- | Yan X, Tao J, Luo HL, Tan LT, Rong W, Li HP, He CZ (2019). A type III effector XopL< | + | Yan X, Tao J, Luo HL, Tan LT, Rong W, Li HP, He CZ (2019). A type III effector XopL< |
===== Acknowledgements ===== | ===== Acknowledgements ===== |